STMN Straumann Holding AG

SWX · CH · Healthcare · Medical Instruments & Supplies · straumann.com

89.80CHF-1.90%Mkt Cap: 16.34B $P/E: 38.873d ago

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and A…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

$18.87BUSDP/E 88.8

SRT

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

BLCO

Bausch + Lomb Corporation Common Shares

$6.11BUSD

Key Statistics

Company

Market Cap16.34B USD

Enterprise Value16.37B USD

Revenue (TTM)3.01B USD

Gross Profit2.04B USD

Net Income (TTM)406.21M USD

Revenue/Share16.56 CHF

Last Price89.80 CHF

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees11.6K

CountryCH

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)38.87

P/E (Forward)23.29

PEG1.12

EV/EBITDA19.11

EV/Revenue5.44

P/S5.43

P/B6.26

EPS (TTM)2.31

EPS (Forward)3.86

52W Range

73.0246% of range109.80

52W High109.80 CHF

52W Low73.02 CHF

Profitability

Gross Margin68.58%

Oper. Margin25.14%

EBITDA Margin28.47%

Profit Margin13.66%

ROE16.47%

ROA9.47%

Growth

Revenue Growth2.30%

Earnings Growth5.80%

Cash Flow & Leverage

Operating CF575.18M USD

CapEx (TTM)255.03M USD

FCF Margin15.13%

FCF Yield2.79%

Net Debt68.50M USD

Net Debt/EBITDA0.08

Balance Sheet

Debt/Equity0.19

Current Ratio2.26

Quick Ratio1.61

Book Value/Sh14.35 CHF

Cash/Share2.61 CHF

Dividends

Fwd Div Rate1.00 CHF

Trail. Div Rate1.00 CHF

Div. Yield1.11%

5Y Avg Yield0.64%

Payout Ratio43.29%

Ex-Div DateApr 21, 2026

Pay DateApr 16, 2025

Splits

Last Split10:1

Split DateApr 20, 2022

Analyst Consensus

Rating1.9 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)113.05 CHF

Upside (mean)+25.9%

Target Range86.00 CHF – 136.00 CHF

86.00+25.9% to mean136.00

# Analysts19

Ownership

Shares Out.159.45M

Float107.62M

Insiders28.80%

Institutions42.29%

Technical

SMA 5096.97 (-7.4%)

SMA 20093.81 (-4.3%)

Beta1.37

S&P 52W Chg14.58%

Avg Vol (30d)425.16K

Avg Vol (10d)382.54K

Technical Indicators

RSI (14)32.9

MACD-1.2144

MACD Signal-0.7581

MACD Hist.-0.4563

BB Upper98.89 CHF

BB Middle94.49 CHF

BB Lower90.09 CHF

BB Width9.31%

ATR (14)2.504 CHF

Vol Ratio (20d)1.84x